BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

185 related articles for article (PubMed ID: 19429434)

  • 21. "Non-hypercalcemic" analogs of 1alpha,25 dihydroxy vitamin D augment the induction of creatine kinase B by estrogen and selective estrogen receptor modulators (SERMS) in osteoblast-like cells and rat skeletal organs.
    Somjen D; Waisman A; Weisman Y; Kaye AM
    J Steroid Biochem Mol Biol; 2000; 72(1-2):79-88. PubMed ID: 10731641
    [TBL] [Abstract][Full Text] [Related]  

  • 22. The selective estrogen receptor modulators (SERMs) raloxifene and tamoxifen improve ANP levels and decrease nuclear translocation of NF-kB in estrogen-deficient rats.
    Lamas AZ; Nascimento AM; Medeiros ARS; Caliman IF; Dalpiaz PLM; Firmes LB; Sousa GJ; Oliveira PWC; Andrade TU; Reis AM; Gouvea SA; Bissoli NS
    Pharmacol Rep; 2017 Aug; 69(4):798-805. PubMed ID: 28591668
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Estrogen and the selective estrogen receptor modulator (SERM) protection against cell death in estrogen receptor alpha and beta expressing U2OS cells.
    Kallio A; Guo T; Lamminen E; Seppänen J; Kangas L; Väänänen HK; Härkönen P
    Mol Cell Endocrinol; 2008 Jul; 289(1-2):38-48. PubMed ID: 18455292
    [TBL] [Abstract][Full Text] [Related]  

  • 24. [Fluid shear stress and raloxifene stimulates the proliferation of osteoblast through regulating the expresstion of β-catenin and estrogen receptor α].
    Tang WR; Liu Y; Li LH; Wu ZB; He Y
    Sichuan Da Xue Xue Bao Yi Xue Ban; 2014 Nov; 45(6):913-8. PubMed ID: 25571714
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Comparative effects of testosterone propionate, oestradiol benzoate, ICI 182,780, tamoxifen and raloxifene on hypothalamic differentiation in the female rat.
    Pinilla L; Barreiro ML; Gonzalez LC; Tena-Sempere M; Aguilar E
    J Endocrinol; 2002 Mar; 172(3):441-8. PubMed ID: 11874692
    [TBL] [Abstract][Full Text] [Related]  

  • 26. The selective estrogen receptor modulators, tamoxifen and raloxifene, impair dendritic cell differentiation and activation.
    Nalbandian G; Paharkova-Vatchkova V; Mao A; Nale S; Kovats S
    J Immunol; 2005 Aug; 175(4):2666-75. PubMed ID: 16081843
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Comparing the effects of 17β-oestradiol and the selective oestrogen receptor modulators, raloxifene and tamoxifen, on prepulse inhibition in female rats.
    Gogos A; van den Buuse M
    Schizophr Res; 2015 Nov; 168(3):634-9. PubMed ID: 25979306
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Differential effects of selective oestrogen receptor modulators (SERMs) tamoxifen, ospemifene and raloxifene on human osteoclasts in vitro.
    Michael H; Härkönen PL; Kangas L; Väänänen HK; Hentunen TA
    Br J Pharmacol; 2007 Jun; 151(3):384-95. PubMed ID: 17420779
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Selective estrogen receptor modulator effects in the rat brain.
    Zhou W; Koldzic-Zivanovic N; Clarke CH; de Beun R; Wassermann K; Bury PS; Cunningham KA; Thomas ML
    Neuroendocrinology; 2002 Jan; 75(1):24-33. PubMed ID: 11810032
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Raloxifene and estradiol benzoate both fully restore hippocampal choline acetyltransferase activity in ovariectomized rats.
    Wu X; Glinn MA; Ostrowski NL; Su Y; Ni B; Cole HW; Bryant HU; Paul SM
    Brain Res; 1999 Nov; 847(1):98-104. PubMed ID: 10564741
    [TBL] [Abstract][Full Text] [Related]  

  • 31. TAS-108, a novel oral steroidal antiestrogenic agent, is a pure antagonist on estrogen receptor alpha and a partial agonist on estrogen receptor beta with low uterotrophic effect.
    Yamamoto Y; Shibata J; Yonekura K; Sato K; Hashimoto A; Aoyagi Y; Wierzba K; Yano S; Asao T; Buzdar AU; Terada T
    Clin Cancer Res; 2005 Jan; 11(1):315-22. PubMed ID: 15671561
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Searching for an ideal SERM: Mining tamoxifen structure-activity relationships.
    Price S; Bender SG; Yahn R; Till NA; Varady S; LaLonde RL
    Bioorg Med Chem Lett; 2021 Nov; 52():128383. PubMed ID: 34592434
    [TBL] [Abstract][Full Text] [Related]  

  • 33. SERMs (selective estrogen receptor modulator), acting as estrogen receptor β agonists in hepatocellular carcinoma cells, inhibit the transforming growth factor-α-induced migration via specific inhibition of AKT signaling pathway.
    Matsushima-Nishiwaki R; Yamada N; Hattori Y; Hosokawa Y; Tachi J; Hori T; Kozawa O
    PLoS One; 2022; 17(1):e0262485. PubMed ID: 35007301
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Identification of selective estrogen receptor modulators by their gene expression fingerprints.
    Zajchowski DA; Kauser K; Zhu D; Webster L; Aberle S; White FA; Liu HL; Humm R; MacRobbie J; Ponte P; Hegele-Hartung C; Knauthe R; Fritzemeier KH; Vergona R; Rubanyi GM
    J Biol Chem; 2000 May; 275(21):15885-94. PubMed ID: 10748166
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Comparative effects of estradiol, methyl-piperidino-pyrazole, raloxifene, and ICI 182 780 on gene expression in the murine uterus.
    Davis AM; Mao J; Naz B; Kohl JA; Rosenfeld CS
    J Mol Endocrinol; 2008 Oct; 41(4):205-17. PubMed ID: 18632874
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Raloxifene induces cell death and inhibits proliferation through multiple signaling pathways in prostate cancer cells expressing different levels of estrogen receptor α and β.
    Rossi V; Bellastella G; De Rosa C; Abbondanza C; Visconti D; Maione L; Chieffi P; Della Ragione F; Prezioso D; De Bellis A; Bellastella A; Sinisi AA
    J Cell Physiol; 2011 May; 226(5):1334-9. PubMed ID: 20945400
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Effects of ospemifene, a novel selective estrogen-receptor modulator, on human breast tissue ex vivo.
    Eigeliene N; Kangas L; Hellmer C; Kauko T; Erkkola R; Härkönen P
    Menopause; 2016 Jul; 23(7):719-30. PubMed ID: 27163517
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Neuroprotective action of raloxifene against hypoxia-induced damage in mouse hippocampal cells depends on ERα but not ERβ or GPR30 signalling.
    Rzemieniec J; Litwa E; Wnuk A; Lason W; Gołas A; Krzeptowski W; Kajta M
    J Steroid Biochem Mol Biol; 2015 Feb; 146():26-37. PubMed ID: 24846829
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Selective estrogen receptor modulators: discrimination of agonistic versus antagonistic activities by gene expression profiling in breast cancer cells.
    Frasor J; Stossi F; Danes JM; Komm B; Lyttle CR; Katzenellenbogen BS
    Cancer Res; 2004 Feb; 64(4):1522-33. PubMed ID: 14973112
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Differential effects of estradiol, raloxifene and tamoxifen on estrogen receptor expression in cultured human skin fibroblasts.
    Haczynski J; Tarkowski R; Jarzabek K; Wolczynski S; Magoffin DA; Czarnocki KJ; Ziegert M; Jakowicki J; Jakimiuk AJ
    Int J Mol Med; 2004 Jun; 13(6):903-8. PubMed ID: 15138633
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 10.